Richardson et al Figure 1.
Richardson et al Figure 1. Schematic representation of main caspase-mediated pathways for the direct anti–multiple myeloma (MM) effect of proteasome inhibitors (bortezomib), immunomodulatory thalidomide derivatives (IMIDs) and dexamethasone (Dex).

Schematic representation of main caspase-mediated pathways for the direct anti–multiple myeloma (MM) effect of proteasome inhibitors (bortezomib), immunomodulatory thalidomide derivatives (IMIDs) and dexamethasone (Dex).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal